Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

• David R. Strayer,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing

  Affiliation AIM ImmunoTech Inc., Philadelphia, Pennsylvania, United States of America

  ⨯
• Diane Young,

  Roles Data curation, Project administration, Validation, Writing – original draft, Writing – review & editing

  Affiliation AIM ImmunoTech Inc., Philadelphia, Pennsylvania, United States of America

  ⨯
• William M. Mitchell

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: bill.mitchell@vanderbilt.edu

  Affiliation Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  https://orcid.org/0000-0001-5024-9777

  ⨯